Evidence map›Paper›PMID 32144589›Full record

ArticleArchives of osteoporosis2020

Osteogenesis imperfecta and rheumatoid arthritis: is there a link?

Laura Otilia Damian, Carmen-Delia Zmarandache, Paulina Vele, Adriana Albu, Cristina Belizna, Alexandra Crăciun

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Archives of osteoporosis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Jaccoud's arthropathy in osteogenesis imperfecta.Journal of rheumatic diseases · 2024
    Article
  4. Rheumatoid arthritis and osteogenesis imperfecta: is there a genetic causal association?Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2022
    Article
  5. Osteogenesis imperfecta and rheumatoid arthritis: connective issues.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Laura Otilia DamianRheumatology Department, Emergency Clinical County Hospital Cluj, 2-4 Clinicilor Street, 400006, Cluj-Napoca, Romania. ldamian.reumatologie@gmail.com.ORCID https://orcid.org/0000-0002-5735-3929
Carmen-Delia ZmarandacheRadiology Department, Emergency Clinical County Hospital Cluj, 3-5 Clinicilor Street, 400006, Cluj-Napoca, Romania.
Paulina VeleRheumatology Department, Emergency Clinical County Hospital Cluj, 2-4 Clinicilor Street, 400006, Cluj-Napoca, Romania.
Adriana Albu"Iuliu Hatieganu" University of Medicine and Pharmacy Cluj, 8 V. Babes Str, 400012, Cluj-Napoca, Romania.
Cristina BeliznaCentre Vasculaire et de la Coagulation CHU (Centre Hospitalier Universitaire), Angers 4 rue Larrey, 49000, Angers, France.
Alexandra Crăciun"Iuliu Hatieganu" University of Medicine and Pharmacy Cluj, 8 V. Babes Str, 400012, Cluj-Napoca, Romania.
Iuliu Hațieganu University of Medicine and Pharmacy · ROCentre Hospitalier Universitaire d'Angers · FRSociedad Española de Reumatología · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present the cases of a mother and daughter with osteogenesis imperfecta, also diagnosed later with rheumatoid arthritis. In our patients finding and treating the over-imposed arthritis improved the joint pain initially attributed to osteogenesis imperfecta. Exploring joint inflammation in this setting could help ease the disease burden. PURPOSE: Osteogenesis imperfecta (OI) is a rare hereditary disease evolving with recurrent fractures upon minor trauma, blue sclerae, and hearing loss. Although inflammation was not generally considered a feature of the disease, systemic inflammation was recently reported in children with OI and in murine models of OI.

methodWe present the cases of a mother and a daughter with OI, without a personal or family history of autoimmune diseases, who were also diagnosed with rheumatoid arthritis seropositive for anti-cyclic citrullinated peptide autoantibodies and rheumatoid factor.

resultsThe genetic tests identified in both patients a deletion in COL1A1 gene (c.3399del, p.Ala1134Profs*105), not previously reported, not present in population databases, creating a premature translational stop signal in the COL1A1 gene in the collagen I major ligand binding region 3. In our patients finding and treating the over-imposed arthritis improved the joint pain initially attributed to OI. Possible pathogenic links between OI and RA are discussed.

conclusionThe prevalence of joint inflammation in OI is unknown and may be underestimated. As musculoskeletal involvement affects the quality of life in most OI patients, exploring this relation may help ease the disease burden.

Indexed as

AgedArthritis, RheumatoidCollagen Type ICollagen Type I, alpha 1 ChainFemaleGenetic Predisposition to DiseaseHumansMiddle AgedOsteogenesis ImperfectaPedigreeCollagen Type ICollagen Type I, alpha 1 ChainAnti-citrullinated peptide antibodiesDisease burdenFracturesOsteogenesis imperfectaRheumatoid arthritisTenascin C

Identifiers

PMID32144589
OpenAlexW3011224030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.